Kewaunee Scientific Announces Results For Third Quarter And Quarterly Dividend
STATESVILLE, N.C., Feb. 25 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced results for its third quarter ended January 31, 2010.
Sales for the quarter were $21,814,000, down from sales of $26,023,000 in the same period last year. Sales were affected by a soft market for small laboratory furniture projects, lower sales to international customers, and unusually bad weather which delayed the start of many construction projects. The lower sales also reflect the typical slowdown in construction activity during the winter months, which did not occur last year. Sales from domestic operations during the quarter were $19,081,000, down from sales of $22,498,000 in the same period last year. Sales from international operations were $2,733,000, down from sales of $3,525,000 in the same period last year.
The order backlog increased to a record $65.5 million at January 31, 2010, up from $60.7 million at January 31, 2009, and $65.2 million at the end of last quarter.
Net earnings for the quarter were $621,000, or $0.24 per diluted share, down from $882,000, or $0.35 per diluted share, in the same period last year. Earnings were unfavorably impacted by lower sales and an after-tax increase in pension expense of $157,000, or $0.06 per diluted share, as compared to the third quarter last year. The pension expense increase primarily resulted from last year's decline in the market value of pension investments."Despite the lower earnings, I am pleased with our progress during the quarter," said William A. Shumaker, President and Chief Executive Officer. "The order backlog is strong at $65.5 million, and outstanding quotations are at record levels. Quotation opportunities in the international marketplace have increased dramatically in recent months. The international marketplace appears to show signs of recovery from the economic slowdown, and we expect to see improved results from our international operations in the fourth quarter. Quotation activity also remains strong in the domestic marketplace for larger laboratory projects, although we expect our results in the short-term will continue to be impacted by changes to construction schedules and project delivery dates. All of our markets remain highly-competitive with aggressive pricing; however, we continue to successfully compete and win projects." Sales for the nine months ended January 31, 2010 were $75,151,000, down from sales of $79,150,000 in the same period last year. Domestic sales for the nine months ended January 31, 2010 were $67,152,000, down from sales of $67,296,000 in the same period last year. Sales from international operations were $7,999,000 for the nine months ended January 31, 2010, down from sales of $11,854,000 in the same period last year. Net earnings for the nine months ended January 31, 2010 were $3,044,000, or $1.18 per diluted share, down from net earnings of $3,327,000, or $1.30 per diluted share, in the same period last year. Earnings for the nine months were unfavorably impacted by an after-tax increase in pension expense of $470,000, or $0.18 per diluted share, as compared to the same period last year. The Company's financial condition continues to be strong. Bank borrowings and capital lease obligations decreased to $3,144,000 at January 31, 2010, down from $6,318,000 at January 31, 2009. Cash on hand was $2,443,000, as compared to 3,089,000 at the end of the same period last year. Working capital increased to $21,327,000 at the end of the quarter, up from $17,749,000 at the end of the same period last year. "As I look forward, I am optimistic about Kewaunee's future," continued Mr. Shumaker. "Our strategies to expand into new markets, introduce new products, and reduce costs are positioning Kewaunee well for long-term growth and success. We also continue to expand our manufacturing capabilities, with the recently announced expansion of our Statesville facility following the move into our new, larger Bangalore factory last summer." In other news, the Company announced today that its Board of Directors approved a cash dividend of ten cents per outstanding share to stockholders of record at the close of business on March 8, 2010, payable on March 22, 2010. Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of scientific and technical furniture. The Company's corporate headquarters are located in Statesville, North Carolina. The Company's manufacturing facilities are located in Statesville and Bangalore, India. The Company has subsidiaries in Singapore and Bangalore that serve the Asian and Middle East markets. Kewaunee Scientific's website is located at http://www.kewaunee.com. Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.
Consolidated Statements of Operations (in thousands, except per share data) (Unaudited) Three Months Ended Nine Months Ended January 31 January 31 2010 2009 2010 2009 ---- ---- ---- ---- Net sales $21,814 $26,023 $75,151 $79,150 Cost of products sold 17,129 21,089 58,492 62,846 ------ ------ ------ ------ Gross profit 4,685 4,934 16,659 16,304 Operating expenses 3,663 3,440 11,605 10,884 ----- ----- ------ ------ Operating earnings 1,022 1,494 5,054 5,420 Other income (expense) -- 3 -- (36) Interest expense (35) (49) (115) (231) --- --- ---- ---- Earnings before income taxes 987 1,448 4,939 5,153 Income tax expense 333 488 1,673 1,595 --- --- ----- ----- Net earnings 654 960 3,266 3,558 Less: net earnings attributable to the noncontrolling interest 33 78 222 231 --- --- --- --- Net earnings attributable to Kewaunee Scientific Corporation $621 $882 $3,044 $3,327 ==== ==== ====== ====== Net earnings per share attributable to Kewaunee Scientific Corporation stockholders Basic $0.24 $0.35 $1.19 $1.30 Diluted $0.24 $0.35 $1.18 $1.30 Weighted average number of common shares outstanding (in thousands) Basic 2,569 2,556 2,562 2,554 Diluted 2,581 2,556 2,570 2,563 Condensed Consolidated Balance Sheets (in thousands) January 31 April 30 2010 2009 ---- ---- (unaudited) Assets ------ Cash and cash equivalents $1,937 $3,559 Restricted cash 506 456 Receivables, less allowances 23,007 24,526 Inventories 7,924 7,839 Prepaid expenses and other current assets 1,585 1,165 ----- ----- Total current assets 34,959 37,545 Net property, plant and equipment 12,609 11,369 Other assets 4,035 3,615 ----- ----- Total Assets $51,603 $52,529 ======= ======= Liabilities and Stockholders' Equity Short-term borrowings $2,909 $5,720 Current obligations under capital leases 96 220 Accounts payable 6,082 8,812 Other current liabilities 4,545 3,911 ----- ----- Total current liabilities 13,632 18,663 ------ ------ Other non-current liabilities 6,672 5,607 ----- ----- Total liabilities 20,304 24,270 Noncontrolling interest 1,625 1,306 Kewaunee Scientific Corporation equity 29,674 26,953 ------ ------ Total equity 31,299 28,259 ------ ------ Total Liabilities and Equity $51,603 $52,529 ======= ======= Contact: D. Michael Parker 704/871-3290SOURCE Kewaunee Scientific Corporation
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV